A detailed history of Mission Wealth Management, LP transactions in Sanofi stock. As of the latest transaction made, Mission Wealth Management, LP holds 7,714 shares of SNY stock, worth $399,430. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,714
Previous 7,828 1.46%
Holding current value
$399,430
Previous $378,000 3.7%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$45.07 - $51.35 $5,137 - $5,853
-114 Reduced 1.46%
7,714 $364,000
Q2 2025

Aug 05, 2025

BUY
$47.62 - $55.44 $12,428 - $14,469
261 Added 3.45%
7,828 $378,000
Q1 2025

Apr 17, 2025

SELL
$48.15 - $59.42 $8,715 - $10,755
-181 Reduced 2.34%
7,567 $419,000
Q4 2024

Feb 06, 2025

BUY
$45.89 - $57.31 $28,497 - $35,589
621 Added 8.71%
7,748 $373,000
Q3 2024

Oct 31, 2024

BUY
$48.54 - $58.53 $15,435 - $18,612
318 Added 4.67%
7,127 $410,000
Q2 2024

Aug 02, 2024

BUY
$45.39 - $50.36 $73,713 - $81,784
1,624 Added 31.32%
6,809 $330,000
Q1 2024

Apr 30, 2024

BUY
$45.75 - $52.48 $46,390 - $53,214
1,014 Added 24.31%
5,185 $251,000
Q4 2023

Feb 05, 2024

SELL
$43.13 - $54.79 $8,065 - $10,245
-187 Reduced 4.29%
4,171 $207,000
Q3 2023

Oct 23, 2023

SELL
$50.95 - $55.2 $17,323 - $18,768
-340 Reduced 7.24%
4,358 $233,000
Q2 2023

Aug 04, 2023

SELL
$50.45 - $57.18 $19,978 - $22,643
-396 Reduced 7.77%
4,698 $253,000
Q1 2023

Apr 07, 2023

SELL
$45.86 - $54.45 $24,259 - $28,804
-529 Reduced 9.41%
5,094 $277,000
Q4 2022

Feb 02, 2023

BUY
$38.86 - $48.55 $4,352 - $5,437
112 Added 2.03%
5,623 $272,000
Q3 2022

Oct 12, 2022

BUY
$37.22 - $100.5 $40,346 - $108,942
1,084 Added 24.49%
5,511 $210,000
Q2 2022

Jul 27, 2022

BUY
$48.99 - $57.46 $216,878 - $254,375
4,427 New
4,427 $221,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $130B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Mission Wealth Management, LP Portfolio

Follow Mission Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mission Wealth Management, LP with notifications on news.